There are a lot of companies (including mine) that have been working on personalised, target, combinatorial, interfering, etc. RNA therapeutics for quite some t

There are a lot of companies (including mine) that have been working on personalised, target, combinatorial, interfering, etc. RNA therapeutics for quite some time. The success of RNA vaccines in the last year has really opened up the potential for pharma partnerships to test and develop these kinds of things. They have built out the infrastructure and there's a broad confidence and awareness of the basic concepts that was previously largely missing. Pharma just really loves proteins. The next 5 years are going to be incredibly exciting - it has the potential to fundamentally change humanity's relationship with many kinds of disease.